-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Maintains Outperform on Elevance Health, Raises Price Target to $465

Benzinga·06/08/2026 17:35:52
Listen to the news
Mizuho analyst Ann Hynes maintains Elevance Health (NYSE:ELV) with a Outperform and raises the price target from $435 to $465.